Graduate School of Medicine Kyoto University
Japanese
HOME
Access Site Map Inquiries
photo
HOME > Contributed Chairs
Contributed Chairs
Department of Translational Clinical Oncology
Department of Immunology and Genomic Medicine
Department of Organ Preservation Technology
Multidisciplinary Cancer Treatment
Respiratory Care and Sleep Control Medicine
リウマチ性疾患制御学講座
臨床腫瘍薬理学
標的治療腫瘍学

> Past Contributed Chairs

Department of Translational Clinical Oncology
-Purpose of Research Construct the clinical systems necessary for the safe, effective implementation of translational clinical oncology, and contribute to the progress of clinical oncology.
-Details of Research In collaboration with the Translational Research Center, research on clinical systems for the safe, effective implementation of translational clinical oncology required for the development of novel cancer treatment. Further, verification of whether or not improved treatment results and/or patient prognosis are observed through the implementation of clinical trials of the many novel cancer
treatment developed in different research fields.

-Research Topics

1. Developmental research on a safe, effective cancer management system for translational clinical oncology
2. Research on effective support systems for the promotion of clinical trials of novel cancer treatment
3. Clinical pharmacological research on translational cancer chemotherapy
-Sponsor Taiho Pharmaceutical Co., Ltd.
-Duration of Endowment From October 2003 to September 2013

Department of Immunology and Genomic Medicine
-Purpose of Research

Fundamental research on the structure of genetic variation in the immune system and its regulation, as well as research on novel treatments for a range of diseases by using immunoregulatory factors.

-Details of Research In collaboration with Immunology and Cell Biology, the Center for Genomic Medicine, Hematology, Transplantation and Immunology, Rheumatology and Clinical Immunology, and oncology treatment projects in a number of clinical departments, carry out fundamental research on immunology and genomic medicine at the same time as offering a graduate-level education on the core content of immunology and genomic medicine with the aim of clinical applications for immunoregulatory substances.

-Research Topics

1. Elucidation of the mechanism of antibody gene diversification based on the genetic variation that defines the immune response
2. Research on the negative immunoregulatory factor PD-1
3. Fundamental research on the molecular-level regulation of the immune response, mechanism of antibody diversification, cytokine function and genome destabilization
-Sponsor

Ono Pharmaceutical Co., Ltd.

-Duration of Endowment

From April 2005 to March 2010

member of Department of Immunology and Genomic Medicine

 

 

-Purpose of Research

We research the mechanisms of functional deterioration of organs, tissues, and cells during preservation. Further, we develop novel methods and techniques to effectively preserve organs, tissues, and cells.

-Details of Research In collaboration with many departments mainly related to organ transplantation, such as Department of Thoracic Surgery and Department of Transplantation and Immunology, we carry out various research for elucidating the mechanisms of functional deterioration after preservation and improving the quality of organs, tissues, and cells to directly benefit patients for those advanced therapies. Further, knowledge on organ, tissue and cell preservation would also provide better results in regenerative medicine. We would like to collaborate many researches, and perform basic as well as pre-clinical studies.

-Research Topics

1. Clinical application of ET-Kyoto solution, which was developed by our department, into various fields of organ transplantation (lung, heart, liver, kidney, islets, and small intestine, etc.).
2. Application of ET-Kyoto solution into various fields. (bone marrow transplantation for leukemia, immuno-cell therapies for cancer, and replantation of amputated digits, etc.)
3. Organ preservation from donation after cardiac death.
-Sponsor

Otsuka Pharmaceutical Co., Ltd.

-Duration of Endowment

From August 2006 to July 2011

 

Multidisciplinary Cancer Treatment

(under construction)

 

 

 

 

 

 

Copyright(c) 2006 Graduate School of Medicine Kyoto University. All rights reserved.